Panjon Ltd. (BSE: 526345) is an Indore, Madhya Pradesh-based company in the Pharmaceuticals industry. With a market capitalisation of ₹33 Cr, it ranks #4,095 by market cap among the 6,197 Indian listed companies on FinBizNet, and #54 of 63 in Pharmaceuticals. At ₹18.70 (as of 16 Nov 2026), the share price is 37.7% below its 52-week high of ₹30.00 and 15.7% above its 52-week low of ₹16.16. The share price is up 6.1% over one year and down 4.2% over three months.
| Current Price | ₹18.70 |
|---|---|
| Market Cap | ₹33 Cr |
| BSE Code | 526345 |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Biotechnology and Life Sciences > Pharmaceuticals |
| P/E Ratio | 69 |
| Return on Equity | 4.32% |
| Return on Assets | 2.08% |
| 52-Week Range | ₹16.16 – ₹30.00 |
| 1-Year Price Change | +6.1% |
| 3-Month Price Change | -4.2% |
| Beta (1Y) | 0.51 |
| Headquarters | Indore, Madhya Pradesh |
| Website | www.panjon.in |
Delivery averaged 90.2% of traded volume across 15 BSE sessions (21 Oct 2026 – 13 Nov 2026).
Panjon Limited manufactures and trades in consumer and pharmaceutical products in India. The company offers tablets, balms, cough syrups and drops, inhalers, hair oil, candies, digestive drops, energy drink, dental care creams, and mouth freshner, as well as awla, khajoor, chatpati, and shoppee. It sells its products under the Panjon, Hinkargiri, KERY, Percy, Swad, and Purti brand names. Panjon Limited was incorporated in 1964 and is based in Indore, India.
1. Trading-This segment operates SwadBazaar.com, an online shopping portal. 2. Manufacturing-This segment manufactures and trades in allopathic and ayurvedic medicines. 3. Pharmaceuticals-This segment markets and sells pharmaceutical products.
1. Manufacturing-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Abbott India Ltd. | ₹56,531 Cr | 36.3 | 34.46% | ₹1,814 Cr | -8.1% |
| Emcure Pharmaceuticals Ltd | ₹42,344 Cr | 47.9 | 19.57% | ₹2,820 Cr | +73.3% |
| Ajanta Pharma Limited | ₹41,474 Cr | 39.4 | 25.39% | ₹1,794 Cr | +27.8% |
| Piramal Pharma Ltd | ₹32,600 Cr | n/m | -4.00% | ₹2,617 Cr | +22.8% |
| RUBICON RESEARCH LIMITED | ₹28,526 Cr | 112.3 | 19.14% | ₹576 Cr | +162.7% |
| Caplin Point Laboratories Ltdte | ₹18,155 Cr | 28.3 | 19.94% | ₹630 Cr | +23.6% |
| Pfizer Ltd. | ₹17,811 Cr | 24.5 | 17.16% | ₹727 Cr | -24.2% |
| Eris Lifesciences Ltd | ₹17,691 Cr | 28.3 | 18.07% | ₹892 Cr | -17.5% |
| Panjon Ltd. | ₹33 Cr | 69 | 4.32% | — | +6.1% |
Listed by market capitalisation. Ratios are shown for context only.
Panjon Ltd. is trading at ₹18.70, with a market capitalisation of ₹33 Cr.
Panjon Ltd. operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Pharmaceuticals).
Panjon Ltd. has a P/E of 69 and a return on equity of 4.32%.
Panjon Ltd. is listed on the BSE under the scrip code 526345.
Panjon Ltd.'s share price is up 6.1% over one year and down 4.2% over three months. Its 52-week range is ₹16.16 to ₹30.00.
Data as of 16 Nov 2026. Descriptive market data only — not investment advice.